Keywords: fda, oks, adderall, xr, adhd, adults, uk-headquartered
FDA OKs Adderall XR for ADHD in adults
Article | 23 August 2004
UK-headquartered Shire Pharmaceuticals says that the US Food and DrugAdministration has approved Adderall XR (mixed amphetamine sales) as a once-daily ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
